SCHEMBL4291189

SCHEMBL4291189

Cc1ccccc1N1CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.72
ALDH1A1 P00352 2/20 0.64
HPGD P15428 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
LMNA P02545 1/20 0.61
MCOLN3 Q8TDD5 1/20 0.61
AKR1C3 P42330 1/20 0.58
SLC18A3 Q16572 1/20 0.58
ATM Q13315 2/20 0.56
KMT2A Q03164 1/20 0.56
HTR7 P34969 2/20 0.54
TSHR P16473 1/20 0.54
AR P10275 3/20 0.53
NPC1 O15118 1/20 0.53
RECQL P46063 1/20 0.53
HSD11B1 P28845 1/20 0.51
HTT P42858 1/20 0.51
ADRA1D P25100 1/20 0.51
ADRA1A P35348 1/20 0.51
ADRA1B P35368 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656303 0.91 ADRB1 (0.62) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL173027 0.91 ADRB1 (0.62) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL329301 0.90 ADRB1 (0.67) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL10118836 0.90 ADRB1 (0.61) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL10679708 0.89 ADRB1 (0.60) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL11206795 0.89 ADRB1 (0.60) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL28587090 0.89 ADRB1 (0.60) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL6736376 0.89 ADRB1 (0.60) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL18408991 0.89 ADRB1 (0.60) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA
Ammonia Solution, Strong SCHEMBL28721086 0.89 ADRB1 (0.60) ADRB1ALDH1A1HPGDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170281773-A1 BET BROMODOMAIN INHIBITORS AND THERAPEUTIC METHODS USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-10-05 US disclosed
US-9675697-B2 BET bromodomain inhibitors and therapeutic methods using the same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-06-13 US disclosed
EP-2265679-B1 FLUOROCARBON POLYMER COATING COMPOSITIONS PPG IND OHIO INC (US) 2017-03-22 EP disclosed
CN-102516172-B 2, 3, 4, 7-tetrahydro-1H-nitrogen azepine compound and preparation method and application thereof UNIV CHINA AGRICULTURAL 2013-09-04 CN disclosed
US-20090258990-A1 FLUOROCARBON POLYMER COMPOSITIONS CAPABLE OF PRODUCING LOW GLOSS COATINGS AND METHODS OF COATING COILS THEREWITH PPG INDUSTRIES OHIO, INC. (US) 2009-10-15 US disclosed
US-20090258987-A1 FLUOROCARBON POLYMER COMPOSITIONS AND METHODS OF COATING COILS THEREWITH PPG INDUSTRIES OHIO, INC. (US) 2009-10-15 US disclosed
WO-2004050606-A1 PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED β-AMINO NITRILES THROUGH THE RING OPENING OF AZIRIDINES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2004-06-17 WO disclosed
US-4788108-A PHOTOPOLYMERIZATION PPG INDUSTRIES, INC. (US) 1988-11-29 US disclosed
EP-0158874-B1 CURABLE IMINATED RESINS FROM AMINOPLASTS AND HYDROXYLCONTAINING CARBOXYLIC ACIDS PPG INDUSTRIES, INC. (US) 1988-06-08 EP disclosed
EP-0158874-A2 Curable iminated resins from aminoplasts and hydroxylcontaining carboxylic acids PPG INDUSTRIES, INC. (US) 1985-10-23 EP disclosed
US-4293457-A POLYESTER; AMINOPLAST CURING AGENT; THERMOPLASTIC ACRYLIC POLYMER; CELLULOSE ACETATE BUTYRATE, EPOXY RESIN, OR VINYL ESTER-VINYL HALIDE COPOLYMER PPG INDUSTRIES, INC. (US) 1981-10-06 US disclosed
US-4232090-A Sealerless primers PPG INDUSTRIES, INC. (US) 1980-11-04 US disclosed
US-4187258-A AMINOPLAST CURING AGENT; POLYESTER, POLYETHER, OR POLYURETHANE, THERMOPLASTIC ACRYLIC RESIN PPG INDUSTRIES, INC. (US) 1980-02-05 US disclosed
US-3966667-A Preparation of non-aqueous thermosetting acrylic polymer dispersions PPG INDUSTRIES, INC. (US) 1976-06-29 US disclosed
US-3963703-A Trialkylammonium -N-[β(1-aziridinyl)] propionoylimines ASHLAND OIL, INC. (US) 1976-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170281773-A1 BET BROMODOMAIN INHIBITORS AND THERAPEUTIC METHODS USING THE SAME BRD4, BRDT, BRD3 ADRB1 3674/4885ALDH1A1 4162/4885HPGD 2888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.